State of the art of ICD programming: Lessons learned and future directions.

M.H. Mastenbroek, S.S. Pedersen, H. Versteeg, P.A. Doevendans, M.M. Meine

Research output: Contribution to journalReview articleScientificpeer-review

3 Downloads (Pure)

Abstract

The lifesaving benefits of implantable cardioverter defibrillator (ICD) therapy are more and more weighted against possible harm (e.g. unnecessary device therapy, procedural complications, device malfunction etc.) which might have adverse effects on patients’ perceived health status and quality of life. Hence, there has been an increasing interest in the optimisation of ICD programming to prevent inappropriate and appropriate but unnecessary device therapy. The purpose of the current report is to give an overview of research into the optimisation of ICD programming and present the design of the on-going ENHANCED-ICD study. The ENHANCED-ICD study is a prospective, safety monitoring study enrolling 60 primary and secondary prophylactic ICD patients at the University Medical Center Utrecht. Patients implanted with any type of ICD with SmartShock technologyTM, and between 18–80 years of age, were eligible to participate. In all patients a prolonged detection of 60/80 intervals was programmed. The primary objective of the study is to investigate whether enhanced programming to further reduce ICD therapies is safe. The secondary objective is to examine the impact of enhanced programming on (i) antitachycardia pacing and shocks (both appropriate and inappropriate) and (ii) quality of life and distress. The first results of the ENHANCED-ICD study are expected in 2015.
Keywords: ENHANCED-ICD, Implantable cardioverter defibrillator, ICD programming, Quality of life
Original languageEnglish
Pages (from-to)415-420
JournalNetherlands Heart Journal
Volume10
DOIs
Publication statusPublished - 2014

Fingerprint

Implantable Defibrillators
Equipment and Supplies

Cite this

Mastenbroek, M. H., Pedersen, S. S., Versteeg, H., Doevendans, P. A., & Meine, M. M. (2014). State of the art of ICD programming: Lessons learned and future directions. Netherlands Heart Journal, 10, 415-420. https://doi.org/10.1007/s12471-014-0582-4
Mastenbroek, M.H. ; Pedersen, S.S. ; Versteeg, H. ; Doevendans, P.A. ; Meine, M.M. / State of the art of ICD programming : Lessons learned and future directions. In: Netherlands Heart Journal. 2014 ; Vol. 10. pp. 415-420.
@article{69add60ffb454206a5ddba18c4c0c441,
title = "State of the art of ICD programming: Lessons learned and future directions.",
abstract = "The lifesaving benefits of implantable cardioverter defibrillator (ICD) therapy are more and more weighted against possible harm (e.g. unnecessary device therapy, procedural complications, device malfunction etc.) which might have adverse effects on patients’ perceived health status and quality of life. Hence, there has been an increasing interest in the optimisation of ICD programming to prevent inappropriate and appropriate but unnecessary device therapy. The purpose of the current report is to give an overview of research into the optimisation of ICD programming and present the design of the on-going ENHANCED-ICD study. The ENHANCED-ICD study is a prospective, safety monitoring study enrolling 60 primary and secondary prophylactic ICD patients at the University Medical Center Utrecht. Patients implanted with any type of ICD with SmartShock technologyTM, and between 18–80 years of age, were eligible to participate. In all patients a prolonged detection of 60/80 intervals was programmed. The primary objective of the study is to investigate whether enhanced programming to further reduce ICD therapies is safe. The secondary objective is to examine the impact of enhanced programming on (i) antitachycardia pacing and shocks (both appropriate and inappropriate) and (ii) quality of life and distress. The first results of the ENHANCED-ICD study are expected in 2015.Keywords: ENHANCED-ICD, Implantable cardioverter defibrillator, ICD programming, Quality of life",
author = "M.H. Mastenbroek and S.S. Pedersen and H. Versteeg and P.A. Doevendans and M.M. Meine",
year = "2014",
doi = "10.1007/s12471-014-0582-4",
language = "English",
volume = "10",
pages = "415--420",
journal = "Netherlands Heart Journal",
issn = "1568-5888",
publisher = "Bohn Stafleu van Loghum",

}

Mastenbroek, MH, Pedersen, SS, Versteeg, H, Doevendans, PA & Meine, MM 2014, 'State of the art of ICD programming: Lessons learned and future directions.' Netherlands Heart Journal, vol. 10, pp. 415-420. https://doi.org/10.1007/s12471-014-0582-4

State of the art of ICD programming : Lessons learned and future directions. / Mastenbroek, M.H.; Pedersen, S.S.; Versteeg, H.; Doevendans, P.A.; Meine, M.M.

In: Netherlands Heart Journal, Vol. 10, 2014, p. 415-420.

Research output: Contribution to journalReview articleScientificpeer-review

TY - JOUR

T1 - State of the art of ICD programming

T2 - Lessons learned and future directions.

AU - Mastenbroek, M.H.

AU - Pedersen, S.S.

AU - Versteeg, H.

AU - Doevendans, P.A.

AU - Meine, M.M.

PY - 2014

Y1 - 2014

N2 - The lifesaving benefits of implantable cardioverter defibrillator (ICD) therapy are more and more weighted against possible harm (e.g. unnecessary device therapy, procedural complications, device malfunction etc.) which might have adverse effects on patients’ perceived health status and quality of life. Hence, there has been an increasing interest in the optimisation of ICD programming to prevent inappropriate and appropriate but unnecessary device therapy. The purpose of the current report is to give an overview of research into the optimisation of ICD programming and present the design of the on-going ENHANCED-ICD study. The ENHANCED-ICD study is a prospective, safety monitoring study enrolling 60 primary and secondary prophylactic ICD patients at the University Medical Center Utrecht. Patients implanted with any type of ICD with SmartShock technologyTM, and between 18–80 years of age, were eligible to participate. In all patients a prolonged detection of 60/80 intervals was programmed. The primary objective of the study is to investigate whether enhanced programming to further reduce ICD therapies is safe. The secondary objective is to examine the impact of enhanced programming on (i) antitachycardia pacing and shocks (both appropriate and inappropriate) and (ii) quality of life and distress. The first results of the ENHANCED-ICD study are expected in 2015.Keywords: ENHANCED-ICD, Implantable cardioverter defibrillator, ICD programming, Quality of life

AB - The lifesaving benefits of implantable cardioverter defibrillator (ICD) therapy are more and more weighted against possible harm (e.g. unnecessary device therapy, procedural complications, device malfunction etc.) which might have adverse effects on patients’ perceived health status and quality of life. Hence, there has been an increasing interest in the optimisation of ICD programming to prevent inappropriate and appropriate but unnecessary device therapy. The purpose of the current report is to give an overview of research into the optimisation of ICD programming and present the design of the on-going ENHANCED-ICD study. The ENHANCED-ICD study is a prospective, safety monitoring study enrolling 60 primary and secondary prophylactic ICD patients at the University Medical Center Utrecht. Patients implanted with any type of ICD with SmartShock technologyTM, and between 18–80 years of age, were eligible to participate. In all patients a prolonged detection of 60/80 intervals was programmed. The primary objective of the study is to investigate whether enhanced programming to further reduce ICD therapies is safe. The secondary objective is to examine the impact of enhanced programming on (i) antitachycardia pacing and shocks (both appropriate and inappropriate) and (ii) quality of life and distress. The first results of the ENHANCED-ICD study are expected in 2015.Keywords: ENHANCED-ICD, Implantable cardioverter defibrillator, ICD programming, Quality of life

U2 - 10.1007/s12471-014-0582-4

DO - 10.1007/s12471-014-0582-4

M3 - Review article

VL - 10

SP - 415

EP - 420

JO - Netherlands Heart Journal

JF - Netherlands Heart Journal

SN - 1568-5888

ER -